ArticleJournal of pharmacokinetics and pharmacodynamics2025

Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin.

Summer Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.